Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
immunotherapy
biological agent |
| gptkbp:category |
gptkb:monoclonal_antibody
biologic therapy |
| gptkbp:example |
gptkb:benralizumab
gptkb:mepolizumab gptkb:reslizumab |
| https://www.w3.org/2000/01/rdf-schema#label |
IL-5 antagonist
|
| gptkbp:mechanismOfAction |
blocks IL-5 activity
|
| gptkbp:routeOfAdministration |
intravenous
subcutaneous injection |
| gptkbp:target |
gptkb:interleukin-5
|
| gptkbp:usedFor |
treatment of eosinophilic asthma
treatment of hypereosinophilic syndrome |
| gptkbp:bfsParent |
gptkb:reslizumab
|
| gptkbp:bfsLayer |
7
|